Researchers used advanced microscopy to uncover important protein structures.
For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of Cincinnati’s Center for Advanced Structural Biology. This breakthrough could lead to the development of more effective therapeutics.
The research, conducted by a team of structural biologists at UC, was published in the Proceedings of the National Academy of Sciences (PNAS).
This is the first publication from the Seegar Lab at UC. Tom Seegar, PhD, Ohio Eminent Scholar and assistant professor in the Department of Molecular and Cellular Biosciences in the College of Medicine, is the corresponding author.
The study’s first authors are Joe Maciag, PhD, a research scientist in the Seegar Lab, and Conner Slone, a graduate student assistant in the same lab.
For the first time, they are visualizing the physical, atomic structure of two protein complexes, observing how they interact, how their functions change, and how this process drives inflammatory signaling.
“If you can see something, you can figure out how it works,” said Seegar. “We are figuring out what this enzyme looks like and how it’s regulated.”
What they saw
The Seegar Lab used advanced cryogenic electron microscopy to reveal the structure of the ADAM17 enzyme bound to its regulator protein, iRhom2, and identified key features essential for its activity. They also pinpointed the critical interaction within the ADAM17-iRhom2 complex that governs how protein substrates are processed.
Scientists have long known that ADAM17 is a vital enzyme found in all cells, playing a key role in development and immune system regulation. It becomes dysregulated in chronic inflammatory diseases and has been linked to conditions such as rheumatoid arthritis, cancer, and Covid-19.
Researchers are now studying how ADAM17 communicates with other proteins involved in immune response and tissue repair. “We know in some cancers and rheumatoid arthritis, way too much signaling is occurring,” said Maciag. “But some treatments create too many side effects, worse than the disease itself.”
Maciag explained that the team is exploring ways to target iRhom2 for more precise therapeutic approaches. They have already identified structural features inside the cell, called the “re-entry loop” of iRhom2, that transmit information from the cell’s interior to its exterior. These structures are essential for ADAM17 to function outside the cell and had not been well understood until now.
Seegar emphasized the human impact. “This work provides a foundation for designing therapies targeting ADAM17-related diseases, offering new strategies to address critical health conditions,” he said.
New research core facility
The ADAM17-iRhom2 Complex contains the first protein structures coming out of UC’s Center for Advanced Structural Biology, established in 2022.
“We are indebted to UC,” said Seegar. “Our work wouldn’t be possible without this research core facility.”
The cryogenic electron microscopy technology being used has transformed structural biology. The center’s focal point is its transmission electron microscope (TEM), which is ideally suited for screening cryo-EM samples and allows researchers to see complex proteins without leaving UC’s campus.
“It’s a privilege to have this microscope in house, and it’s exciting to use it to solve these structures,” said Maciag. “It’s important to our field of cellular biology and will help drive research forward and how we approach our understanding of inflammation in known disease states.”
The Seegar Lab used UC’s Advanced Research Computing Center (ARC) for data processing, allowing them to keep their data, used to create a 3D model of the ADAM17-iRhom2 Complex, on campus as well.
Moving forward, Seegar’s lab plans to research iRhom2 more closely.
“These adapter proteins are not well understood,” said Slone. “Our research will be in understanding them and will be driven by specificity. Ideally, controlling these will allow researchers to control disease states.”
Reference: “Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex” by Joseph J. Maciag, Conner E. Slone, Hala F. Alnajjar, Maria F. Rich, Bryce Guion, Igal Ifergan, Carl P. Blobel and Tom C. M. Seegar, 13 June 2025, Proceedings of the National Academy of Sciences.
DOI: 10.1073/pnas.2500732122
The study was funded by the National Institute of General Medicine Sciences and with support from a University of Cincinnati Research Innovation/Pilot Grant.
News
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
